Allianz Asset Management
PRAX icon

Allianz Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Allianz Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.62M Buy
25,744
+11,714
+83% +$3.71M 0.01% 1139
2026
Q1 		$4.52M Buy
14,030
+11,630
+485% +$3.6M ﹤0.01% 1212
2025
Q4 		$707K Buy
+2,400
New +$447K ﹤0.01% 1788

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Allianz Asset Management's PRAX Position: Q2 2026 in Review

Allianz Asset Management increased its Praxis Precision Medicines (PRAX) stake by 83% in Q2 2026, buying an estimated $3.71M and bringing the position to 25,744 shares worth $8.62M. The position accounts for 0.01% of the portfolio, ranked #1139.

Allianz Asset Management first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Allianz Asset Management held 25,744 shares of Praxis Precision Medicines worth $8.62M as of Q2 2026.
  • Allianz Asset Management bought 11,714 Praxis Precision Medicines shares in Q2 2026, an estimated $3.71M.
  • Praxis Precision Medicines made up 0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1139 holding.
  • Allianz Asset Management first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.